SAREPTA THERAPEUTICS, INC. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
SAREPTA THERAPEUTICS, INC. (SRPT) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $210.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2019-11-07
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2019-09-30 was -$16.00K.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2019-06-30 was -$4.00K, a 104.35% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2019-03-31 was $230.00K, a 13.86% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2018-12-31 was $140.00K, a 64.71% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2018 was $374.00K, a 9.04% increase from fiscal 2017.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2017 was $343.00K, a 70.51% decline from fiscal 2016.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2016 was $1.16M, a 247.16% increase from fiscal 2015.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2015 was $335.00K, a 24.07% increase from fiscal 2014.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$20.00K derived: sum of 2 quarters · filed 2019-11-07 | $210.00K 10-Q · filed 2019-11-07 | $350.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $226.00K 10-Q · filed 2019-08-07 | $366.00K derived: sum of 3 quarters · filed 2019-08-07 | $306.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | $230.00K 10-Q · filed 2019-05-08 | $370.00K derived: sum of 2 quarters · filed 2019-05-08 | $310.00K derived: sum of 3 quarters · filed 2019-11-07 | $402.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $80.00K derived: sum of 2 quarters · filed 2019-11-07 | $172.00K derived: sum of 3 quarters · filed 2019-11-07 | $374.00K 10-K · filed 2019-02-28 |
| 2018-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $32.00K derived: sum of 2 quarters · filed 2019-11-07 | $234.00K 10-Q · filed 2019-11-07 | $319.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $294.00K 10-Q · filed 2019-08-07 | $379.00K derived: sum of 3 quarters · filed 2019-08-07 | $372.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $202.00K 10-Q · filed 2019-05-08 | $287.00K derived: sum of 2 quarters · filed 2019-05-08 | $280.00K derived: sum of 3 quarters · filed 2019-05-08 | $366.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $78.00K derived: sum of 2 quarters · filed 2019-02-28 | $164.00K derived: sum of 3 quarters · filed 2019-02-28 | $343.00K 10-K · filed 2019-02-28 |
| 2017-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $79.00K derived: sum of 2 quarters · filed 2018-10-31 | $258.00K 10-Q · filed 2018-10-31 | $191.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $265.00K 10-Q · filed 2018-08-08 | $198.00K derived: sum of 3 quarters · filed 2019-02-28 | $1.17M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $179.00K 10-Q · filed 2018-05-03 | $112.00K derived: sum of 2 quarters · filed 2019-02-28 | $1.08M derived: sum of 3 quarters · filed 2019-02-28 | $1.15M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $904.00K derived: sum of 2 quarters · filed 2019-02-28 | $971.00K derived: sum of 3 quarters · filed 2019-02-28 | $1.16M 10-K · filed 2019-02-28 |
| 2016-09-30 | $971.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $1.04M derived: sum of 2 quarters · filed 2017-11-01 | $1.23M 10-Q · filed 2017-11-01 | $1.46M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $259.00K 10-Q · filed 2017-08-03 | $489.00K derived: sum of 3 quarters · filed 2018-03-01 | $424.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $192.00K 10-Q · filed 2017-05-04 | $422.00K derived: sum of 2 quarters · filed 2018-03-01 | $357.00K derived: sum of 3 quarters · filed 2018-03-01 | $427.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $165.00K derived: sum of 2 quarters · filed 2018-03-01 | $235.00K derived: sum of 3 quarters · filed 2018-03-01 | $335.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | -$65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $5.00K derived: sum of 2 quarters · filed 2016-11-07 | $105.00K 10-Q · filed 2016-11-07 | $188.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $170.00K 10-Q · filed 2016-08-09 | $253.00K derived: sum of 3 quarters · filed 2017-02-28 | $240.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $100.00K 10-Q · filed 2016-05-05 | $183.00K derived: sum of 2 quarters · filed 2017-02-28 | $170.00K derived: sum of 3 quarters · filed 2017-02-28 | $170.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $70.00K derived: sum of 2 quarters · filed 2017-02-28 | $70.00K derived: sum of 3 quarters · filed 2017-02-28 | $270.00K 10-K · filed 2017-02-28 |
| 2014-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$13.00K derived: sum of 2 quarters · filed 2015-11-05 | $187.00K 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $200.00K 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $200.00K 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | $195.00K 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |